Ursprung des Netzwerks ersten Grades von Peter Wendel
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
GU Ventures AB
 GU Ventures AB Investment ManagersFinance GU Ventures AB (GU Ventures) is a venture capital subsidiary of University of Gothenburg founded in 1995. The firm is headquartered in Gothenburg, Sweden.
2
| Subsidiary | Investment Managers | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter Wendel
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALZINOVA AB | Pharmaceuticals: Major | Chairman | |
| RLS GLOBAL AB (PUBL) | Biotechnology | Chief Executive Officer | |
Medfield Diagnostics AB
 Medfield Diagnostics AB Medical SpecialtiesHealth Technology Medfield Diagnostics AB. operates as medical company, which engages in the development, sale and marketing of microwave tomography technology. It also distributes diagnostic instrument, which allows the treatment in time for stroke victims through diagnosis at the strike units and in ambulances. The company was founded by Mikael Persson and Andreas Fhager in 2005 and is headquartered in Gothenburg, Sweden. | Medical Specialties | Chief Executive Officer | |
| REDWOOD PHARMA AB | Pharmaceuticals: Major | Chairman | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Chairman | |
Strongbone AB
 Strongbone AB BiotechnologyHealth Technology Strongbone AB develops drug candidates based on a new type of low molecular weight substances called peptidyl derivatives. Its drug targets bone diseases such as osteoporosis, periodontal disease, and rheumatism. Strongbone was founded by Ulf Holger Lerner and Anders Olof Grubb on November 8, 2011 and is headquartered in Gothenburg, Sweden. | Biotechnology | Chairman | |
Innovativa Mindre Life Science
 Innovativa Mindre Life Science Miscellaneous Commercial ServicesCommercial Services Innovativa Mindre Life Science is an association of small and medium-sized Swedish companies that conduct research in the field of pharmaceuticals and medical technology. | Miscellaneous Commercial Services | Director/Board Member | |
| OBSERVE MEDICAL ASA | Electronic Equipment/Instruments | Chief Executive Officer | |
| Föreningen Innovativa Mindre Läkemedelsföretag | Director/Board Member | ||
Abigo Medical AB
 Abigo Medical AB Pharmaceuticals: MajorHealth Technology Abigo Medical AB manufactures and sells pharmaceutical products. The product it offers are Sorbact, Otovent, Moniri and Otinova. The company was founded by Jan G. Smith and Leif Smith in 1989 and is headquartered in Askim, Sweden. | Pharmaceuticals: Major | Public Communications Contact | |
| University of California San Diego | College/University | Undergraduate Degree | |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Founder | |
| Medtronic Synectics AB | Corporate Officer/Principal | ||
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
MIVAC Development AB
 MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Biotechnology | Director/Board Member | |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Chalmers University of Technology | College/University | Graduate Degree | |
| MENTICE AB | Medical Specialties | Sales & Marketing | |
| LUXBRIGHT AB | Medical Specialties | Chief Executive Officer | |
| Adi Yoga AB | Director/Board Member |
Statistik
International
| Schweden | 19 |
| Vereinigte Staaten | 3 |
| Norwegen | 2 |
| Dänemark | 2 |
Sektoral
| Health Technology | 14 |
| Commercial Services | 3 |
| Consumer Services | 3 |
| Finance | 2 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 5 |
| Chief Executive Officer | 4 |
| Chairman | 4 |
| Corporate Officer/Principal | 4 |
| Private Equity Investor | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Björn Oskar Larsson | 20 |
| Gregory Carson | 4 |
- Börse
- Insiders
- Peter Wendel
- Unternehmensverbindungen
